Long-acting GLP-1/Amylin(QL Biopharm)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameLong-acting GLP-1/Amylin(QL Biopharm)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionAmylin receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsAmylin ReceptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing QL Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing QL Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A